Objective
The creation of a databank on pharmaceutical products was requested by the European Parliament as an additional measure of market transparency in response to the Commission proposal for a Council Directive related to market transparency regulating prices of pharmaceutics for humans.
The creation of a databank on pharmaceutical products was requested by the European Parliament as an additional measure of market transparency in response to a Commission proposal for a Council Directive related to market transparency regulating prices of pharmaceutics for humans.
After completion of the first phase of data collection from competent authorities and storage of the data in the European Pharmaceutical Database (ECPHIN), a second development phase was initiated and carried out.
The second phase extended the list of data elements to complete the storage of economic and administrative information and facilitate more comprehensive search possibilities.
In addition, data transparency was increased by the definition of equivalences between national terms for pharmaceutical form and route of administration as well as the incorporation of chemical abstract service (CAS) number and anatomic therapeutic class (ATC) codes.
The third phase forsees a further expansion of data elements to comprise remaining summary product characteristics (SPC) elements as well as increases transparency of data through modification of the display program and the definition of equivalencies of remaining terms.
Access to the Production Databank is available to Commission Services and Regulatory Authorities in Member States.
The third phase in 1993 foresees a further expansion of data elements to comprise remaining SPC (Summary Product Characteristics elements as well as increases transparency of data through modification of the display program and the definition of equivalencies of remaining terms.
Programme(s)
Topic(s)
Data not availableCall for proposal
Data not availableFunding Scheme
Data not availableCoordinator
21020 Ispra
Italy